Gene "ADAMTS13"
Found 2 records
Gene information
Gene symbol:
ADAMTS13
See related:
Ensembl: ENSG00000160323, Gene ID: 11093
Additive variants :
Undetected
Genetic interaction partners
No data
Modifier statisitcs
Record:
2 
Disorder:
1 
Vriant:
2 
Reference:
1 
Effect type:
Expressivity(2)  
Modifier effect:
Altered effect of disease causing mutation(2)  
Details：
  • Variant 1:
    ADAMTS13:rs34024143
    Gene:
    ADAMTS13
    Genomic location:
    dbSNP ID:
    rs34024143
    Target disease:
    Thrombotic thrombocytopenic purpura(DOID_10772)
    Effect type:
    Expressivity 
    Modifier effect:
    Altered effect of disease causing mutation 
    Evidence:
    Gene activity study 
    Effect:
    R7W and Q448E were positive modifiers of ADAMTS13 secretion in the context of P618A and A732V
    Reference:
    PMID16160007
    Title:
    Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation
    Species studied:
    Human
    Abstract:
    Sequence analysis of the ADAMTS13 locus of 2 patients with hereditary thrombotic thrombocytopenic purpura (TTP) revealed the homozygous presence of 4 single nucleotide polymorphisms (SNPs) (R7W, Q448E, P618A, A732V) and a rare missense mutation (R1336W). Analysis of the individual effect of any amino acid exchanges showed that several sequence variations can interact with each other, thereby altering the phenotype of ADAMTS13 deficiency. Introduction of polymorphisms R7W, Q448E, and A732V had no or only minor effects on ADAMTS13 secretion. In contrast, P618A, R1336W, and the A732V-P618A combination strongly reduced ADAMTS13-specific activity and antigen levels. Surprisingly, R7W and Q448E were positive modifiers of ADAMTS13 secretion in the context of P618A and A732V but neither could rescue the severely reduced specific activity conferred by P618A. However, in the context of R1336W, polymorphisms R7W and Q448E enhanced the detrimental effect of the missense mutation and led to undetectable enzyme activity. We show that dependent on the sequence context, the same polymorphisms might be either positive or negative modifiers of gene expression. Our results might therefore be widely relevant to understanding the influence of polymorphisms on the phenotypic expression of complex diseases.
  • Variant 2:
    ADAMTS13:rs2301612
    Gene:
    ADAMTS13
    Genomic location:
    dbSNP ID:
    rs2301612
    Target disease:
    Thrombotic thrombocytopenic purpura(DOID_10772)
    Effect type:
    Expressivity 
    Modifier effect:
    Altered effect of disease causing mutation 
    Evidence:
    Gene activity study 
    Effect:
    R7W and Q448E were positive modifiers of ADAMTS13 secretion in the context of P618A and A732V
    Reference:
    PMID16160007
    Title:
    Modulation of ADAMTS13 secretion and specific activity by a combination of common amino acid polymorphisms and a missense mutation
    Species studied:
    Human
    Abstract:
    Sequence analysis of the ADAMTS13 locus of 2 patients with hereditary thrombotic thrombocytopenic purpura (TTP) revealed the homozygous presence of 4 single nucleotide polymorphisms (SNPs) (R7W, Q448E, P618A, A732V) and a rare missense mutation (R1336W). Analysis of the individual effect of any amino acid exchanges showed that several sequence variations can interact with each other, thereby altering the phenotype of ADAMTS13 deficiency. Introduction of polymorphisms R7W, Q448E, and A732V had no or only minor effects on ADAMTS13 secretion. In contrast, P618A, R1336W, and the A732V-P618A combination strongly reduced ADAMTS13-specific activity and antigen levels. Surprisingly, R7W and Q448E were positive modifiers of ADAMTS13 secretion in the context of P618A and A732V but neither could rescue the severely reduced specific activity conferred by P618A. However, in the context of R1336W, polymorphisms R7W and Q448E enhanced the detrimental effect of the missense mutation and led to undetectable enzyme activity. We show that dependent on the sequence context, the same polymorphisms might be either positive or negative modifiers of gene expression. Our results might therefore be widely relevant to understanding the influence of polymorphisms on the phenotypic expression of complex diseases.